Patents by Inventor Teodorica L. Bugawan

Teodorica L. Bugawan has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Association of polymorphisms in IL4-related genes with autoimmune disease
    Patent number: 7205106
    Abstract: The present invention provides methods and reagents for determining sequence variants present at the IL4 receptor, IL-4 and IL-13 loci, which facilitate identifying individuals at risk for type 1 diabetes.
    Type: Grant
    Filed: October 8, 2002
    Date of Patent: April 17, 2007
    Assignee: Roche Molecular Systems, Inc.
    Inventors: Daniel B. Mirel, Henry A. Erlich, Teodorica L. Bugawan, Janelle A. Noble, Ann Maria Valdes
  • Detection of susceptibility to autoimmune diseases
    Publication number: 20040126794
    Abstract: The present invention provides methods and reagents for detecting an individual's increased or decreased risk for type 1 diabetes, also known as, insulin dependent diabetes mellitus (“IDDM”).
    Type: Application
    Filed: September 25, 2003
    Publication date: July 1, 2004
    Inventors: Teodorica L. Bugawan, Henry A. Erlich
  • IL-4 receptor sequence variation associated with type 1 diabetes
    Publication number: 20030152951
    Abstract: The present invention provides methods and reagents for determining sequence variants present at the IL4R locus, which facilitates identifying individuals at risk for type 1 diabetes.
    Type: Application
    Filed: July 3, 2002
    Publication date: August 14, 2003
    Inventors: Daniel B. Mirel, Henry A. Erlich, Teodorica L. Bugawan, Janelle A. Noble, Ana Maria Valdez
  • Methods and reagents for HLA class I A locus DNA typing
    Patent number: 5451512
    Abstract: Primers for amplification of specific nucleic acid sequences of the second and third exon of HLA Class I A gene and probes for identifying polymorphic sequences contained in the amplified DNA can be used in processes for typing homozygous or heterozygous samples from a variety of sources and for detecting allelic variants not distinguishable by serological methods. This HLA-A DNA typing system can be used in a forward or reverse dot-blot format that is simple and rapid to perform, produces detectable signals in minutes, and can be used for tissue typing, determining individual identity, and identifying disease susceptible individuals.
    Type: Grant
    Filed: September 28, 1993
    Date of Patent: September 19, 1995
    Assignee: Hoffmann-La Roche Inc.
    Inventors: Raymond J. Apple, Teodorica L. Bugawan, Henry A. Erlich